The Association Analysis Between CYP24A1 Genetic Polymorphisms and the Risk of Ischemic Stroke in Chinese Han Population

Overview

Journal Brain Behav

Specialty Psychology

Date 2019 Dec 25

PMID 31872978

Citations 12

Authors

Wei Yang

Fenghui Ma

Li Wang

Xue He

Hengxun Zhang

Jianwen Zheng

Yuhe Wang

Tianbo Jin

Dongya Yuan

Yongjun He

Affiliations

Soon will be listed here.

Abstract

Aims: Stroke is a complicated neurological disease and the second leading cause of death in the world. We aimed to investigate the association between CYP24A1 genetic polymorphisms and ischemic stroke risk.

Methods: In this case-control study, four single-nucleotide polymorphisms of CYP24A1 were selected and genotyped by MassARRAY platform in Chinese Han population. Odds ratios and 95% confidence intervals were calculated via logistic regression analysis with adjustment in genetic models.

Results: Our results indicated that CYP24A1 variant (rs1570669) was associated with the decreased risk of ischemic stroke (OR = 0.60, p < .001). Stratification analysis showed that the rs6068816 could enhance the ischemic stroke risk by 1.64 times (OR = 1.64, p = .028), while rs1570669 played protective role (OR = 0.63, p = .044) in age >64 years. The rs2762934 had an increased ischemic stroke susceptibility (OR = 1.62, p = .033); however, rs1570669 might reduce stroke risk (OR = 0.61, p = .015) in age ≤64 years. The rs1570669 depressed ischemic stroke susceptibility both in female and male patients (OR = 0.46, p = .002; OR = 0.69, p = .033, respectively), and rs2296241 would weaken the risk in male (OR = 0.63, p = .012). The rs1570669 was associated with decreased risk of ischemic stroke with hypertension (OR = 0.56, p = .042).

Conclusion: Our study gave the evidences that CYP24A1 genetic polymorphisms were significantly associated with ischemic stroke patients, which would provide useful information of assessment or possible diagnostic markers for ischemic stroke.

Citing Articles

Association Between CYP24A1 Polymorphisms and Bladder Cancer Risk in the Chinese Han Population.

Zhang T, Hu B, Xu S, Wang Y, Zhang H, Li X Biochem Genet. 2024; .

PMID: 38642176 DOI: 10.1007/s10528-024-10771-z.

SNPs in cytochrome P450 genes decide on the fate of individuals with genetic predisposition to Parkinson's disease.

Petkova-Kirova P, Baas S, Wagenpfeil G, Hartz P, Unger M, Bernhardt R Front Pharmacol. 2023; 14:1244516.

PMID: 37601072 PMC: 10436510. DOI: 10.3389/fphar.2023.1244516.

Associations of vitamin D-related single nucleotide polymorphisms with post-stroke depression among ischemic stroke population.

Sun D, Song M, Zeng C, Chen H, Zhang J, Liu F Front Psychiatry. 2023; 14:1148047.

PMID: 37404714 PMC: 10317012. DOI: 10.3389/fpsyt.2023.1148047.

gene polymorphisms and susceptibility to ischemic stroke in a Chinese Han population.

Liu G, Duan Y Front Neurosci. 2022; 16:1030551.

PMID: 36532271 PMC: 9752905. DOI: 10.3389/fnins.2022.1030551.

Genetic loci, rs17817449 and rs6567160, known for obesity and the risk of stroke events among middle-aged and older Chinese people.

Zhong Q, Zhu F Front Neurol. 2022; 13:1036750.

PMID: 36530622 PMC: 9755202. DOI: 10.3389/fneur.2022.1036750.

References

Gorelick P . The global burden of stroke: persistent and disabling. Lancet Neurol. 2019; 18(5):417-418. DOI: 10.1016/S1474-4422(19)30030-4. View

. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1151-1210. PMC: 5605883. DOI: 10.1016/S0140-6736(17)32152-9. View

Jacobs E, Van Pelt C, Forster R, Zaidi W, Hibler E, Galligan M . CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells. Cancer Res. 2013; 73(8):2563-73. PMC: 3630267. DOI: 10.1158/0008-5472.CAN-12-4134. View

Jones G, Prosser D, Kaufmann M . 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D. Arch Biochem Biophys. 2011; 523(1):9-18. DOI: 10.1016/j.abb.2011.11.003. View

Osanai M, Lee G . CYP24A1-induced vitamin D insufficiency promotes breast cancer growth. Oncol Rep. 2016; 36(5):2755-2762. DOI: 10.3892/or.2016.5072. View

Kleindorfer D, Khoury J, Moomaw C, Alwell K, Woo D, Flaherty M . Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke. 2010; 41(7):1326-31. PMC: 2904073. DOI: 10.1161/STROKEAHA.109.575043. View

Roff A, Wilson R . A novel SNP in a vitamin D response element of the CYP24A1 promoter reduces protein binding, transactivation, and gene expression. J Steroid Biochem Mol Biol. 2008; 112(1-3):47-54. PMC: 2749287. DOI: 10.1016/j.jsbmb.2008.08.009. View

Ozcelik A, Oner T, Demirdogen B, Bek V, Demirkaya S, Adali O . Genetic polymorphisms of vitamin D3 metabolizing CYP24A1 and CYP2R1 enzymes in Turkish patients with ischemic stroke. Neurol Res. 2018; 40(5):364-371. DOI: 10.1080/01616412.2018.1446281. View

Gabriel S, Ziaugra L, Tabbaa D . SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet. 2009; Chapter 2:Unit 2.12. DOI: 10.1002/0471142905.hg0212s60. View

10.

Schwarz N, Nicholls S, Psaltis P . Vitamin D and Cardiovascular Disease. Heart Lung Circ. 2018; 27(8):903-906. DOI: 10.1016/j.hlc.2018.05.098. View

11.

. Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2016; 15(7):695-707. PMC: 4943223. DOI: 10.1016/S1474-4422(16)00102-2. View

12.

Shen H, Bielak L, Ferguson J, Streeten E, Yerges-Armstrong L, Liu J . Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification. Arterioscler Thromb Vasc Biol. 2010; 30(12):2648-54. PMC: 2988112. DOI: 10.1161/ATVBAHA.110.211805. View

13.

Yang W, Ma F, Wang L, He X, Zhang H, Zheng J . The association analysis between CYP24A1 genetic polymorphisms and the risk of ischemic stroke in Chinese Han population. Brain Behav. 2019; 10(2):e01503. PMC: 7010572. DOI: 10.1002/brb3.1503. View

14.

Tarcin O, Yavuz D, Ozben B, Telli A, Ogunc A, Yuksel M . Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab. 2009; 94(10):4023-30. DOI: 10.1210/jc.2008-1212. View

15.

BLUNT J, DeLuca H, Schnoes H . 25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. Biochemistry. 1968; 7(10):3317-22. DOI: 10.1021/bi00850a001. View

16.

Jones G, Prosser D, Kaufmann M . Cytochrome P450-mediated metabolism of vitamin D. J Lipid Res. 2013; 55(1):13-31. PMC: 3927478. DOI: 10.1194/jlr.R031534. View

17.

Boehme A, Esenwa C, Elkind M . Stroke Risk Factors, Genetics, and Prevention. Circ Res. 2017; 120(3):472-495. PMC: 5321635. DOI: 10.1161/CIRCRESAHA.116.308398. View

18.

Gretarsdottir S, Thorleifsson G, Manolescu A, Styrkarsdottir U, Helgadottir A, Gschwendtner A . Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol. 2008; 64(4):402-9. DOI: 10.1002/ana.21480. View

19.

Cordeiro I, Nzwalo H, Sa F, Ferreira R, Alonso I, Afonso L . Shifting the CARASIL paradigm: report of a non-Asian family and literature review. Stroke. 2015; 46(4):1110-2. DOI: 10.1161/STROKEAHA.114.006735. View

20.

Poole K, Loveridge N, Barker P, Halsall D, Rose C, Reeve J . Reduced vitamin D in acute stroke. Stroke. 2005; 37(1):243-5. DOI: 10.1161/01.STR.0000195184.24297.c1. View